查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2102655

動物用藥品市場預測至2034年－全球分析（依動物種類、產品類型、藥物類別、給藥途徑、劑型、通路、治療應用、最終用戶、處方類型及地區分類）

Veterinary Pharmaceuticals Market Forecasts to 2034 - Global Analysis By Animal Type, Product Type, Drug Class, Route of Administration, Dosage Form, Distribution Channel, Therapeutic Application, End User, Prescription Type, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球動物用藥品市場規模將達到 585 億美元，並在預測期內以 8.2% 的複合年成長率成長，到 2034 年將達到 1099 億美元。

動物用藥品涵蓋用於預防、診斷和治療動物疾病的藥品、疫苗和治療產品。市場的目標客戶包括伴侶動物（如犬、牛、馬、鳥類和其他寵物）以及牲畜（如牛、豬、家禽、綿羊、山羊、水產養殖物種和其他牲畜）。產品類型包括抗感染藥、驅蟲藥、抗發炎藥、止痛藥、疫苗、荷爾蒙製劑、生殖保健產品、營養治療產品、鎮靜劑和麻醉劑、皮膚科產品、循環系統藥物、心血管藥物、消化器官系統藥物和其他治療類別。全球肉類消費量的成長、寵物飼養量的增加、對動物健康和福利日益成長的關注以及對食品安全和通用感染疾病日益成長的擔憂是推動市場擴張的主要因素。

全球肉品消費量的成長和對畜牧業生產力需求的增加

全球對動物性蛋白質和畜產品的需求不斷成長，是動物用藥品市場的主要驅動力。人口成長、收入提高和飲食結構變化正在推動肉類、牛奶和雞蛋的消費，尤其是在發展中地區。畜牧養殖戶正在實施動物健康管理技術，以提高生產力、預防疾病爆發並確保食品安全。疫苗、感染疾病物和驅蟲藥等動物用藥品對於維持畜群的健康和生產力至關重要。隨著畜牧業集約化程度的提高以及人們對動物疾病對生產力影響的認知不斷增強，獸藥在牛、家禽、豬和水產養殖領域的應用日益廣泛，市場持續強勁成長。

法規的複雜性和獲得批准所需的時間

動物用藥品法規環境複雜，審核流程漫長，對市場發展構成重大限制。動物用藥品上市前需經過嚴格的安全性、有效性和品質測試，核准週期因地區而異。產品註冊、生產標準和標籤等方面的監管要求繁多且耗費資源。法規的變更，包括抗菌藥物使用的限制，需要企業不斷調整以適應變化。合規成本是一項沉重的負擔，尤其對於中小型生產商而言。這些監管負擔可能導致新產品上市延遲、限制某些產品的市場准入、增加研發成本，最終限制市場成長。

伴侶動物醫療費用不斷上漲

人們日益關注伴侶動物的健康，寵物照護支出不斷成長，這為動物用藥品市場的發展帶來了巨大的機會。寵物飼主越來越希望為他們心愛的寵物提供先進的醫療保健服務，包括預防醫學、診斷服務和治療。寵物「擬人化」的趨勢促使人們更願意投資於寵物藥品，包括疫苗、驅蟲藥、皮膚病產品和慢性病管理藥物。寵物數量的成長和可支配收入的增加正在推動伴侶動物藥品市場的擴張。隨著全球醫療費用支出的持續成長，犬、貓和其他寵物的藥品市場佔有率也不斷擴大。

關於抗生素抗藥性的擔憂和相關規定

人們對抗生素抗藥性的日益關注以及對獸用抗生素使用的監管限制，對動物用藥品市場構成了重大威脅。公共衛生部門正在實施更嚴格的肉類動物抗生素使用規定，以確保其有效性。對某些抗生素類別的限制正在縮小治療選擇範圍，並減少市場機會。消費者對無抗生素肉品的需求，促使畜牧業減少抗生素的使用。這些趨勢迫使製藥公司投資替代療法並重新評估產品系列。抗生素抗藥性的威脅可能會限制感染疾病物領域的成長，並需要對新產品開發進行大量投資。

新型冠狀病毒（COVID-19）的影響：

新冠疫情對動物用藥品市場產生了複雜的影響。供應鏈中斷，包括原料供應和物流中斷，影響了生產和分銷。畜牧業作為一項必需產業，持續維持對動物用藥品的需求。隨著疫情封鎖期間寵物飼養量的增加以及獸醫服務轉向遠距醫療，對伴侶動物用藥品的需求仍然強勁。疫情凸顯了動物健康在食品安全和預防通用感染疾病的重要性。疫情過後，隨著伴侶動物消費、畜牧業生產以及人們對動物健康重要性的認知不斷提高，市場已強勁復甦。

在預測期內，「畜牧業」細分市場預計將佔據最大的市場佔有率。

預計在預測期內，「畜牧業」細分市場將佔據最大的市場佔有率，這主要得益於肉類畜牧業生產規模龐大、全球肉類和乳製品消費量不斷成長，以及畜群整體健康管理中對藥品的迫切需求。畜牧業，包括牛、豬、家禽、綿羊、山羊和養殖品種，構成了大規模的需要治療的動物群體，因此需要使用多種藥品。畜牧業生產的經濟重要性使該細分市場受益匪淺，因為生產力和疾病管理直接影響生產者的盈利。政府的動物疫病控制計劃和獸醫服務也促進了藥品的消耗。隨著全球蛋白質需求的持續成長，獸藥仍保持最大的市場佔有率。

預計在預測期內，「疫苗」細分市場將呈現最高的複合年成長率。

在預測期內，疫苗領域預計將呈現最高的成長率，這主要得益於人們對疾病預防日益重視、對通用感染疾病的擔憂不斷加劇，以及針對新發和現有動物疾病的疫苗研發不斷擴展。疫苗對於預防感染疾病、減少抗生素使用、確保畜牧業食品安全至關重要。隨著人們對預防性醫療保健益處的認知不斷提高，伴侶動物疫苗市場也不斷擴張。重組疫苗、載體疫苗和DNA疫苗等疫苗技術的創新正在擴大疫苗的應用範圍。疾病監測的加強和政府疫苗接種計劃的擴大正在促進疫苗的普及。隨著醫療保健重要性的不斷提升，疫苗產品領域正經歷最快的成長。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這得益於其先進的獸醫保健基礎設施、高標準的畜牧生產以及在伴侶動物醫療保健方面的大量支出。美國和加拿大已建立起完善的動物醫藥產業，擁有健全的法規結構和充足的產品供應。集約化程度不斷提高的畜牧業生產水準正在推動藥品消費。該地區較高的寵物擁有率和在伴侶動物方面的大量支出也支撐著市場成長。憑藉其先進的獸醫保健系統和高額支出，北美在市場中保持主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於畜牧業生產的成長、肉類消費的擴大、伴侶動物數量的增加，以及包括中國、印度、印尼和東南亞國家在內的各國對動物健康的日益關注。該地區龐大的畜牧業生產部門對藥品產生了巨大的需求。可支配收入的增加和都市化推動了寵物飼養量的成長。政府在獸醫服務和疾病控制方面的改進提高了藥品的供應量。人們對動物健康和福利重要性的認知不斷提高，以及食品安全標準的提高，都在推動市場成長。隨著畜牧業和寵物數量的持續成長，亞太地區正經歷全球動物醫藥市場成長最快的時期之一。

免費客製化服務：

所有購買此報告的客戶均可從以下免費自訂選項中選擇一項：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球動物用藥品市場：依動物類型分類

  • 伴侶動物
    • 狗
    • 貓
    • 馬
    • 鳥
    • 其他伴侶動物
  • 家畜
    • 牛
    • 豬
    • 家禽
    • 羊
    • 山羊
    • 水產養殖
    • 其他牲畜

第6章 全球動物用藥品市場：依產品類型分類

  • 抗感染藥物
  • 殺蟲劑
  • 抗發炎藥
  • 止痛藥
  • 疫苗
  • 荷爾蒙製劑
  • 生殖健康產品
  • 營養療法
  • 鎮靜劑和麻醉劑
  • 皮膚科產品
  • 消化器官系統藥物
  • 循環系統藥物
  • 呼吸系統藥物
  • 其他產品類型

第7章 全球動物用藥品市場：依藥物類別分類

  • 抗生素
  • 抗病毒藥物
  • 抗真菌藥物
  • 驅蟲
  • NSAIDs
  • 皮質類固醇
  • 內分泌藥物
  • 免疫調節劑
  • 生物製劑
  • 其他藥物分類

第8章 全球動物用藥品市場：依給藥途徑分類

  • 口服
  • 注射藥物
  • 外用
  • 乳房內給藥
  • 鼻內給藥
  • 眼科
  • 耳朵
  • 其他給藥途徑

第9章 全球動物用藥品市場：依劑型分類

  • 藥片
  • 膠囊
  • 口服溶液和懸浮液
  • 粉末
  • 注射液
  • 藥膏和乳霜
  • 噴
  • 毛孔導引配方
  • 博拉斯代理人
  • 預混合料
  • 其他劑型

第10章：全球動物用藥品市場：依通路分類

  • 動物醫院
  • 動物診所
  • 零售藥房
  • 網路藥房
  • 農資商店
  • 動物用藥品批發商
  • 其他分銷管道

第11章 全球動物用藥品市場：依治療應用分類

  • 感染疾病
  • 寄生蟲病
  • 肌肉骨骼疾病
  • 疼痛管理
  • 皮膚病
  • 胃腸道疾病
  • 呼吸系統疾病
  • 生殖健康
  • 代謝性疾病
  • 心血管疾病
  • 其他治療用途

第12章 全球動物用藥品市場：依最終用戶分類

  • 動物醫院
  • 動物診所
  • 畜牧場
  • 動物收容所
  • 研究機構
  • 居家照護/寵物飼主

第13章 全球動物用藥品市場：依處方類型分類

  • 處方藥
  • 非處方藥

第14章 全球動物用藥品市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第15章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第16章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品上市及法規核准
  • 擴大生產能力和投資
  • 其他策略舉措

第17章：公司簡介

  • Zoetis Inc.
  • Merck Animal Health
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim Animal Health
  • Ceva Sante Animale
  • Virbac SA
  • Vetoquinol SA
  • Dechra Pharmaceuticals PLC
  • Phibro Animal Health Corporation
  • IDEXX Laboratories, Inc.
  • Chanelle Pharma Group
  • Norbrook Laboratories Limited
  • HIPRA
  • Ourofino Saude Animal
  • Kyoritsu Seiyaku Corporation
  • Huvepharma AD
  • Indian Immunologicals Limited
  • Ashish Life Science Pvt. Ltd.
Product Code: SMRC38406

According to Stratistics MRC, the Global Veterinary Pharmaceuticals Market is accounted for $58.5 billion in 2026 and is expected to reach $109.9 billion by 2034 growing at a CAGR of 8.2% during the forecast period. Veterinary pharmaceuticals encompass drugs, vaccines, and therapeutic products designed for the prevention, diagnosis, and treatment of diseases in animals. The market serves companion animals including dogs, cats, horses, birds, and other pets, as well as livestock animals including cattle, swine, poultry, sheep, goats, aquaculture species, and other farm animals. Product categories include anti-infectives, parasiticides, anti-inflammatory drugs, analgesics, vaccines, hormonal preparations, reproductive health products, nutritional therapeutics, sedatives and anesthetics, dermatological products, gastrointestinal drugs, cardiovascular drugs, respiratory drugs, and other therapeutic classes. Growing global meat consumption, rising pet ownership, increasing focus on animal health and welfare, and growing concerns about food safety and zoonotic diseases are key drivers of market expansion.

Market Dynamics:

Driver:

Rising global meat consumption and demand for livestock productivity

The increasing global demand for animal protein and livestock products is a primary driver for the veterinary pharmaceuticals market. Growing populations, rising incomes, and changing dietary patterns are driving meat, milk, and egg consumption, particularly in developing regions. Livestock producers are adopting veterinary health management practices to improve productivity, prevent disease outbreaks, and ensure food safety. Veterinary pharmaceuticals including vaccines, anti-infectives, and parasiticides are essential for maintaining herd health and production efficiency. The intensification of livestock production and growing awareness of animal disease impacts on productivity are driving pharmaceutical adoption across cattle, poultry, swine, and aquaculture sectors, sustaining strong market growth.

Restraint:

Regulatory complexities and approval timelines

The complex regulatory environment and lengthy approval processes for veterinary pharmaceuticals represent a major restraint for the market. Veterinary drugs require rigorous safety, efficacy, and quality testing before market authorization, with approval timelines varying across jurisdictions. Regulatory requirements for product registration, manufacturing standards, and labeling are extensive and resource-intensive. Changing regulations, including restrictions on antimicrobial use, require continuous adaptation. Compliance costs are significant, particularly for smaller manufacturers. These regulatory burdens may slow new product introductions, limit market access for certain products, and increase development costs, potentially constraining market growth.

Opportunity:

Growth in companion animal health spending

The increasing focus on companion animal health and rising pet care expenditure presents significant opportunities for veterinary pharmaceuticals market expansion. Pet owners are increasingly seeking advanced medical care for their animals, including preventive care, diagnostic services, and therapeutic treatments. The humanization of pets has led to greater willingness to invest in pharmaceuticals including vaccines, parasiticides, dermatological products, and chronic disease management. The growing pet population and rising disposable incomes are expanding the companion animal pharmaceutical market. As companion animal health spending continues increasing globally, pharmaceutical products for dogs, cats, and other pets capture growing market share.

Threat:

Antimicrobial resistance concerns and restrictions

Growing concerns about antimicrobial resistance and regulatory restrictions on veterinary antibiotic use pose significant threats to the veterinary pharmaceuticals market. Public health authorities are implementing stricter regulations on antimicrobial use in food-producing animals to preserve antibiotic effectiveness. Restrictions on certain antimicrobial classes limit treatment options and reduce market opportunities. Consumer demand for antibiotic-free meat products creates pressure for reduced antibiotic use in livestock production. These trends are forcing pharmaceutical companies to invest in alternatives and adapt product portfolios. The antimicrobial resistance threat may limit growth in the anti-infectives segment and require significant investment in new product development.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the veterinary pharmaceuticals market. Supply chain disruptions including raw material availability and logistics affected production and distribution. Livestock production continued as an essential industry, maintaining demand for veterinary pharmaceuticals. Companion animal pharmaceutical demand remained strong as pet ownership increased during lockdowns and veterinary services adapted with telemedicine. The pandemic highlighted the importance of animal health in food security and zoonotic disease prevention. Post-pandemic, the market has recovered strongly, with continued growth in companion animal spending, livestock production, and awareness of animal health importance.

The Livestock Animals segment is expected to be the largest during the forecast period

The Livestock Animals segment is expected to account for the largest market share during the forecast period, driven by the massive scale of food animal production, growing global meat and dairy consumption, and essential pharmaceutical needs in herd health management. Livestock animals including cattle, swine, poultry, sheep, goats, and aquaculture species represent large treatment populations requiring extensive pharmaceutical use. The segment benefits from the economic importance of livestock production, with productivity and disease management directly affecting producer profitability. Government animal disease control programs and veterinary services contribute to pharmaceutical consumption. As global protein demand continues rising, livestock animal pharmaceuticals maintain the largest market share.

The Vaccines segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Vaccines segment is predicted to witness the highest growth rate, fueled by increasing focus on disease prevention, growing concerns about zoonotic diseases, and expanding vaccine development for emerging and existing animal diseases. Vaccines are essential for preventing infectious diseases, reducing antibiotic use, and ensuring food safety in livestock production. The growing companion animal vaccination market is expanding with awareness of preventive healthcare benefits. Innovations in vaccine technology including recombinant vaccines, vectored vaccines, and DNA vaccines are expanding application possibilities. Increasing disease surveillance and government vaccination programs support adoption. As preventive healthcare continues gaining importance, vaccines deliver the fastest product segment growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by advanced veterinary healthcare infrastructure, high livestock production standards, and significant companion animal health spending. The United States and Canada have well-established veterinary pharmaceutical industries with strong regulatory frameworks and extensive product availability. High livestock production with intensification drives pharmaceutical consumption. The region's high pet ownership rates and substantial companion animal spending support market growth. With advanced veterinary healthcare systems and high spending, North America maintains its dominant market position.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by rising livestock production, growing meat consumption, expanding companion animal populations, and increasing focus on animal health across countries including China, India, Indonesia, and Southeast Asia. The region's large livestock production sectors create substantial pharmaceutical demand. Growing disposable incomes and urbanization are increasing companion animal ownership. Government veterinary service development and disease control programs support pharmaceutical adoption. Increasing awareness of animal health and welfare benefits and rising food safety standards drive market growth. As livestock production and companion animal populations continue expanding, Asia Pacific delivers the fastest veterinary pharmaceuticals market growth globally.

Key players in the market

Some of the key players in Veterinary Pharmaceuticals Market include Zoetis Inc., Merck Animal Health, Elanco Animal Health Incorporated, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Virbac S.A., Vetoquinol S.A., Dechra Pharmaceuticals PLC, Phibro Animal Health Corporation, IDEXX Laboratories, Inc., Chanelle Pharma Group, Norbrook Laboratories Limited, HIPRA, Ourofino Saude Animal, Kyoritsu Seiyaku Corporation, Huvepharma AD, Indian Immunologicals Limited, and Ashish Life Science Pvt. Ltd.

Key Developments:

In June 2026, Elanco announced plans to establish Elanco Ventures, backed by a $25 million multi-year capital commitment to invest in next-generation therapeutics, digital health technologies, and One Health collaborative systems.

In June 2026, Merck Animal Health entered into a definitive agreement to acquire TARGAN Inc., a privately held poultry ag-tech innovator. The transaction integrates TARGAN's WingScan(TM) automated high-speed vision technology-which gender-sorts up to 160,000 chicks per hour-alongside Merck's comprehensive commercial respiratory and coccidiosis vaccine portfolio.

In May 2026, Boehringer Ingelheim partnered with the World Small Animal Veterinary Association (WSAVA) to publish a comprehensive global study mapping the "hidden impacts" of preventive veterinary care, highlighting that 87% of clinicians identify early-stage detection of subtle chronic pain as their most overlooked diagnostic role.

Animal Types Covered:

  • Companion Animals
  • Livestock Animals

Product Types Covered:

  • Anti-Infectives
  • Parasiticides
  • Anti-Inflammatory Drugs
  • Analgesics
  • Vaccines
  • Hormonal Preparations
  • Reproductive Health Products
  • Nutritional Therapeutics
  • Sedatives and Anesthetics
  • Dermatological Products
  • Gastrointestinal Drugs
  • Cardiovascular Drugs
  • Respiratory Drugs
  • Other Product Types

Drug Classes Covered:

  • Antibiotics
  • Antivirals
  • Antifungals
  • Antiparasitics
  • NSAIDs
  • Corticosteroids
  • Endocrine Drugs
  • Immunomodulators
  • Biologics
  • Other Drug Classes

Routes of Administration Covered:

  • Oral
  • Injectable
  • Topical
  • Intramammary
  • Intranasal
  • Ophthalmic
  • Otic
  • Other Routes of Administration

Dosage Forms Covered:

  • Tablets
  • Capsules
  • Oral Solutions and Suspensions
  • Powders
  • Injectable Solutions
  • Ointments and Creams
  • Sprays
  • Pour-On Formulations
  • Boluses
  • Premixes
  • Other Dosage Forms

Distribution Channels Covered:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Retail Pharmacies
  • Online Pharmacies
  • Farm Supply Stores
  • Veterinary Distributors
  • Other Distribution Channels

Therapeutic Applications Covered:

  • Infectious Diseases
  • Parasitic Diseases
  • Musculoskeletal Disorders
  • Pain Management
  • Dermatological Disorders
  • Gastrointestinal Disorders
  • Respiratory Disorders
  • Reproductive Health
  • Metabolic Disorders
  • Cardiovascular Disorders
  • Other Therapeutic Applications

End Users Covered:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Animal Farms
  • Animal Shelters
  • Research Institutes
  • Homecare/Pet Owners

Prescription Types Covered:

  • Prescription Medicines
  • Over-the-Counter (OTC) Medicines

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Veterinary Pharmaceuticals Market, By Animal Type

  • 5.1 Companion Animals
    • 5.1.1 Dogs
    • 5.1.2 Cats
    • 5.1.3 Horses
    • 5.1.4 Birds
    • 5.1.5 Other Companion Animals
  • 5.2 Livestock Animals
    • 5.2.1 Cattle
    • 5.2.2 Swine
    • 5.2.3 Poultry
    • 5.2.4 Sheep
    • 5.2.5 Goats
    • 5.2.6 Aquaculture
    • 5.2.7 Other Livestock Animals

6 Global Veterinary Pharmaceuticals Market, By Product Type

  • 6.1 Anti-Infectives
  • 6.2 Parasiticides
  • 6.3 Anti-Inflammatory Drugs
  • 6.4 Analgesics
  • 6.5 Vaccines
  • 6.6 Hormonal Preparations
  • 6.7 Reproductive Health Products
  • 6.8 Nutritional Therapeutics
  • 6.9 Sedatives and Anesthetics
  • 6.10 Dermatological Products
  • 6.11 Gastrointestinal Drugs
  • 6.12 Cardiovascular Drugs
  • 6.13 Respiratory Drugs
  • 6.14 Other Product Types

7 Global Veterinary Pharmaceuticals Market, By Drug Class

  • 7.1 Antibiotics
  • 7.2 Antivirals
  • 7.3 Antifungals
  • 7.4 Antiparasitics
  • 7.5 NSAIDs
  • 7.6 Corticosteroids
  • 7.7 Endocrine Drugs
  • 7.8 Immunomodulators
  • 7.9 Biologics
  • 7.10 Other Drug Classes

8 Global Veterinary Pharmaceuticals Market, By Route of Administration

  • 8.1 Oral
  • 8.2 Injectable
  • 8.3 Topical
  • 8.4 Intramammary
  • 8.5 Intranasal
  • 8.6 Ophthalmic
  • 8.7 Otic
  • 8.8 Other Routes of Administration

9 Global Veterinary Pharmaceuticals Market, By Dosage Form

  • 9.1 Tablets
  • 9.2 Capsules
  • 9.3 Oral Solutions and Suspensions
  • 9.4 Powders
  • 9.5 Injectable Solutions
  • 9.6 Ointments and Creams
  • 9.7 Sprays
  • 9.8 Pour-On Formulations
  • 9.9 Boluses
  • 9.10 Premixes
  • 9.11 Other Dosage Forms

10 Global Veterinary Pharmaceuticals Market, By Distribution Channel

  • 10.1 Veterinary Hospitals
  • 10.2 Veterinary Clinics
  • 10.3 Retail Pharmacies
  • 10.4 Online Pharmacies
  • 10.5 Farm Supply Stores
  • 10.6 Veterinary Distributors
  • 10.7 Other Distribution Channels

11 Global Veterinary Pharmaceuticals Market, By Therapeutic Application

  • 11.1 Infectious Diseases
  • 11.2 Parasitic Diseases
  • 11.3 Musculoskeletal Disorders
  • 11.4 Pain Management
  • 11.5 Dermatological Disorders
  • 11.6 Gastrointestinal Disorders
  • 11.7 Respiratory Disorders
  • 11.8 Reproductive Health
  • 11.9 Metabolic Disorders
  • 11.10 Cardiovascular Disorders
  • 11.11 Other Therapeutic Applications

12 Global Veterinary Pharmaceuticals Market, By End User

  • 12.1 Veterinary Hospitals
  • 12.2 Veterinary Clinics
  • 12.3 Animal Farms
  • 12.4 Animal Shelters
  • 12.5 Research Institutes
  • 12.6 Homecare/Pet Owners

13 Global Veterinary Pharmaceuticals Market, By Prescription Type

  • 13.1 Prescription Medicines
  • 13.2 Over-the-Counter (OTC) Medicines

14 Global Veterinary Pharmaceuticals Market, By Geography

  • 14.1 North America
    • 14.1.1 United States
    • 14.1.2 Canada
    • 14.1.3 Mexico
  • 14.2 Europe
    • 14.2.1 United Kingdom
    • 14.2.2 Germany
    • 14.2.3 France
    • 14.2.4 Italy
    • 14.2.5 Spain
    • 14.2.6 Netherlands
    • 14.2.7 Belgium
    • 14.2.8 Sweden
    • 14.2.9 Switzerland
    • 14.2.10 Poland
    • 14.2.11 Rest of Europe
  • 14.3 Asia Pacific
    • 14.3.1 China
    • 14.3.2 Japan
    • 14.3.3 India
    • 14.3.4 South Korea
    • 14.3.5 Australia
    • 14.3.6 Indonesia
    • 14.3.7 Thailand
    • 14.3.8 Malaysia
    • 14.3.9 Singapore
    • 14.3.10 Vietnam
    • 14.3.11 Rest of Asia Pacific
  • 14.4 South America
    • 14.4.1 Brazil
    • 14.4.2 Argentina
    • 14.4.3 Colombia
    • 14.4.4 Chile
    • 14.4.5 Peru
    • 14.4.6 Rest of South America
  • 14.5 Rest of the World (RoW)
    • 14.5.1 Middle East
      • 14.5.1.1 Saudi Arabia
      • 14.5.1.2 United Arab Emirates
      • 14.5.1.3 Qatar
      • 14.5.1.4 Israel
      • 14.5.1.5 Rest of Middle East
    • 14.5.2 Africa
      • 14.5.2.1 South Africa
      • 14.5.2.2 Egypt
      • 14.5.2.3 Morocco
      • 14.5.2.4 Rest of Africa

15 Strategic Market Intelligence

  • 15.1 Industry Value Network and Supply Chain Assessment
  • 15.2 White-Space and Opportunity Mapping
  • 15.3 Product Evolution and Market Life Cycle Analysis
  • 15.4 Channel, Distributor, and Go-to-Market Assessment

16 Industry Developments and Strategic Initiatives

  • 16.1 Mergers and Acquisitions
  • 16.2 Partnerships, Alliances, and Joint Ventures
  • 16.3 New Product Launches and Regulatory Approvals
  • 16.4 Capacity Expansion and Investments
  • 16.5 Other Strategic Initiatives

17 Company Profiles

  • 17.1 Zoetis Inc.
  • 17.2 Merck Animal Health
  • 17.3 Elanco Animal Health Incorporated
  • 17.4 Boehringer Ingelheim Animal Health
  • 17.5 Ceva Sante Animale
  • 17.6 Virbac S.A.
  • 17.7 Vetoquinol S.A.
  • 17.8 Dechra Pharmaceuticals PLC
  • 17.9 Phibro Animal Health Corporation
  • 17.10 IDEXX Laboratories, Inc.
  • 17.11 Chanelle Pharma Group
  • 17.12 Norbrook Laboratories Limited
  • 17.13 HIPRA
  • 17.14 Ourofino Saude Animal
  • 17.15 Kyoritsu Seiyaku Corporation
  • 17.16 Huvepharma AD
  • 17.17 Indian Immunologicals Limited
  • 17.18 Ashish Life Science Pvt. Ltd.

List of Tables

  • Table 1 Global Veterinary Pharmaceuticals Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Veterinary Pharmaceuticals Market Outlook, By Animal Type (2023-2034) ($MN)
  • Table 3 Global Veterinary Pharmaceuticals Market Outlook, By Companion Animals (2023-2034) ($MN)
  • Table 4 Global Veterinary Pharmaceuticals Market Outlook, By Dogs (2023-2034) ($MN)
  • Table 5 Global Veterinary Pharmaceuticals Market Outlook, By Cats (2023-2034) ($MN)
  • Table 6 Global Veterinary Pharmaceuticals Market Outlook, By Horses (2023-2034) ($MN)
  • Table 7 Global Veterinary Pharmaceuticals Market Outlook, By Birds (2023-2034) ($MN)
  • Table 8 Global Veterinary Pharmaceuticals Market Outlook, By Other Companion Animals (2023-2034) ($MN)
  • Table 9 Global Veterinary Pharmaceuticals Market Outlook, By Livestock Animals (2023-2034) ($MN)
  • Table 10 Global Veterinary Pharmaceuticals Market Outlook, By Cattle (2023-2034) ($MN)
  • Table 11 Global Veterinary Pharmaceuticals Market Outlook, By Swine (2023-2034) ($MN)
  • Table 12 Global Veterinary Pharmaceuticals Market Outlook, By Poultry (2023-2034) ($MN)
  • Table 13 Global Veterinary Pharmaceuticals Market Outlook, By Sheep (2023-2034) ($MN)
  • Table 14 Global Veterinary Pharmaceuticals Market Outlook, By Goats (2023-2034) ($MN)
  • Table 15 Global Veterinary Pharmaceuticals Market Outlook, By Aquaculture (2023-2034) ($MN)
  • Table 16 Global Veterinary Pharmaceuticals Market Outlook, By Other Livestock Animals (2023-2034) ($MN)
  • Table 17 Global Veterinary Pharmaceuticals Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 18 Global Veterinary Pharmaceuticals Market Outlook, By Anti-Infectives (2023-2034) ($MN)
  • Table 19 Global Veterinary Pharmaceuticals Market Outlook, By Parasiticides (2023-2034) ($MN)
  • Table 20 Global Veterinary Pharmaceuticals Market Outlook, By Anti-Inflammatory Drugs (2023-2034) ($MN)
  • Table 21 Global Veterinary Pharmaceuticals Market Outlook, By Analgesics (2023-2034) ($MN)
  • Table 22 Global Veterinary Pharmaceuticals Market Outlook, By Vaccines (2023-2034) ($MN)
  • Table 23 Global Veterinary Pharmaceuticals Market Outlook, By Hormonal Preparations (2023-2034) ($MN)
  • Table 24 Global Veterinary Pharmaceuticals Market Outlook, By Reproductive Health Products (2023-2034) ($MN)
  • Table 25 Global Veterinary Pharmaceuticals Market Outlook, By Nutritional Therapeutics (2023-2034) ($MN)
  • Table 26 Global Veterinary Pharmaceuticals Market Outlook, By Sedatives and Anesthetics (2023-2034) ($MN)
  • Table 27 Global Veterinary Pharmaceuticals Market Outlook, By Dermatological Products (2023-2034) ($MN)
  • Table 28 Global Veterinary Pharmaceuticals Market Outlook, By Gastrointestinal Drugs (2023-2034) ($MN)
  • Table 29 Global Veterinary Pharmaceuticals Market Outlook, By Cardiovascular Drugs (2023-2034) ($MN)
  • Table 30 Global Veterinary Pharmaceuticals Market Outlook, By Respiratory Drugs (2023-2034) ($MN)
  • Table 31 Global Veterinary Pharmaceuticals Market Outlook, By Other Product Types (2023-2034) ($MN)
  • Table 32 Global Veterinary Pharmaceuticals Market Outlook, By Drug Class (2023-2034) ($MN)
  • Table 33 Global Veterinary Pharmaceuticals Market Outlook, By Antibiotics (2023-2034) ($MN)
  • Table 34 Global Veterinary Pharmaceuticals Market Outlook, By Antivirals (2023-2034) ($MN)
  • Table 35 Global Veterinary Pharmaceuticals Market Outlook, By Antifungals (2023-2034) ($MN)
  • Table 36 Global Veterinary Pharmaceuticals Market Outlook, By Antiparasitics (2023-2034) ($MN)
  • Table 37 Global Veterinary Pharmaceuticals Market Outlook, By NSAIDs (2023-2034) ($MN)
  • Table 38 Global Veterinary Pharmaceuticals Market Outlook, By Corticosteroids (2023-2034) ($MN)
  • Table 39 Global Veterinary Pharmaceuticals Market Outlook, By Endocrine Drugs (2023-2034) ($MN)
  • Table 40 Global Veterinary Pharmaceuticals Market Outlook, By Immunomodulators (2023-2034) ($MN)
  • Table 41 Global Veterinary Pharmaceuticals Market Outlook, By Biologics (2023-2034) ($MN)
  • Table 42 Global Veterinary Pharmaceuticals Market Outlook, By Other Drug Classes (2023-2034) ($MN)
  • Table 43 Global Veterinary Pharmaceuticals Market Outlook, By Route of Administration (2023-2034) ($MN)
  • Table 44 Global Veterinary Pharmaceuticals Market Outlook, By Oral (2023-2034) ($MN)
  • Table 45 Global Veterinary Pharmaceuticals Market Outlook, By Injectable (2023-2034) ($MN)
  • Table 46 Global Veterinary Pharmaceuticals Market Outlook, By Topical (2023-2034) ($MN)
  • Table 47 Global Veterinary Pharmaceuticals Market Outlook, By Intramammary (2023-2034) ($MN)
  • Table 48 Global Veterinary Pharmaceuticals Market Outlook, By Intranasal (2023-2034) ($MN)
  • Table 49 Global Veterinary Pharmaceuticals Market Outlook, By Ophthalmic (2023-2034) ($MN)
  • Table 50 Global Veterinary Pharmaceuticals Market Outlook, By Otic (2023-2034) ($MN)
  • Table 51 Global Veterinary Pharmaceuticals Market Outlook, By Other Routes of Administration (2023-2034) ($MN)
  • Table 52 Global Veterinary Pharmaceuticals Market Outlook, By Dosage Form (2023-2034) ($MN)
  • Table 53 Global Veterinary Pharmaceuticals Market Outlook, By Tablets (2023-2034) ($MN)
  • Table 54 Global Veterinary Pharmaceuticals Market Outlook, By Capsules (2023-2034) ($MN)
  • Table 55 Global Veterinary Pharmaceuticals Market Outlook, By Oral Solutions and Suspensions (2023-2034) ($MN)
  • Table 56 Global Veterinary Pharmaceuticals Market Outlook, By Powders (2023-2034) ($MN)
  • Table 57 Global Veterinary Pharmaceuticals Market Outlook, By Injectable Solutions (2023-2034) ($MN)
  • Table 58 Global Veterinary Pharmaceuticals Market Outlook, By Ointments and Creams (2023-2034) ($MN)
  • Table 59 Global Veterinary Pharmaceuticals Market Outlook, By Sprays (2023-2034) ($MN)
  • Table 60 Global Veterinary Pharmaceuticals Market Outlook, By Pour-On Formulations (2023-2034) ($MN)
  • Table 61 Global Veterinary Pharmaceuticals Market Outlook, By Boluses (2023-2034) ($MN)
  • Table 62 Global Veterinary Pharmaceuticals Market Outlook, By Premixes (2023-2034) ($MN)
  • Table 63 Global Veterinary Pharmaceuticals Market Outlook, By Other Dosage Forms (2023-2034) ($MN)
  • Table 64 Global Veterinary Pharmaceuticals Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 65 Global Veterinary Pharmaceuticals Market Outlook, By Veterinary Hospitals (2023-2034) ($MN)
  • Table 66 Global Veterinary Pharmaceuticals Market Outlook, By Veterinary Clinics (2023-2034) ($MN)
  • Table 67 Global Veterinary Pharmaceuticals Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 68 Global Veterinary Pharmaceuticals Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 69 Global Veterinary Pharmaceuticals Market Outlook, By Farm Supply Stores (2023-2034) ($MN)
  • Table 70 Global Veterinary Pharmaceuticals Market Outlook, By Veterinary Distributors (2023-2034) ($MN)
  • Table 71 Global Veterinary Pharmaceuticals Market Outlook, By Other Distribution Channels (2023-2034) ($MN)
  • Table 72 Global Veterinary Pharmaceuticals Market Outlook, By Therapeutic Application (2023-2034) ($MN)
  • Table 73 Global Veterinary Pharmaceuticals Market Outlook, By Infectious Diseases (2023-2034) ($MN)
  • Table 74 Global Veterinary Pharmaceuticals Market Outlook, By Parasitic Diseases (2023-2034) ($MN)
  • Table 75 Global Veterinary Pharmaceuticals Market Outlook, By Musculoskeletal Disorders (2023-2034) ($MN)
  • Table 76 Global Veterinary Pharmaceuticals Market Outlook, By Pain Management (2023-2034) ($MN)
  • Table 77 Global Veterinary Pharmaceuticals Market Outlook, By Dermatological Disorders (2023-2034) ($MN)
  • Table 78 Global Veterinary Pharmaceuticals Market Outlook, By Gastrointestinal Disorders (2023-2034) ($MN)
  • Table 79 Global Veterinary Pharmaceuticals Market Outlook, By Respiratory Disorders (2023-2034) ($MN)
  • Table 80 Global Veterinary Pharmaceuticals Market Outlook, By Reproductive Health (2023-2034) ($MN)
  • Table 81 Global Veterinary Pharmaceuticals Market Outlook, By Metabolic Disorders (2023-2034) ($MN)
  • Table 82 Global Veterinary Pharmaceuticals Market Outlook, By Cardiovascular Disorders (2023-2034) ($MN)
  • Table 83 Global Veterinary Pharmaceuticals Market Outlook, By Other Therapeutic Applications (2023-2034) ($MN)
  • Table 84 Global Veterinary Pharmaceuticals Market Outlook, By End User (2023-2034) ($MN)
  • Table 85 Global Veterinary Pharmaceuticals Market Outlook, By Veterinary Hospitals (2023-2034) ($MN)
  • Table 86 Global Veterinary Pharmaceuticals Market Outlook, By Veterinary Clinics (2023-2034) ($MN)
  • Table 87 Global Veterinary Pharmaceuticals Market Outlook, By Animal Farms (2023-2034) ($MN)
  • Table 88 Global Veterinary Pharmaceuticals Market Outlook, By Animal Shelters (2023-2034) ($MN)
  • Table 89 Global Veterinary Pharmaceuticals Market Outlook, By Research Institutes (2023-2034) ($MN)
  • Table 90 Global Veterinary Pharmaceuticals Market Outlook, By Homecare/Pet Owners (2023-2034) ($MN)
  • Table 91 Global Veterinary Pharmaceuticals Market Outlook, By Prescription Type (2023-2034) ($MN)
  • Table 92 Global Veterinary Pharmaceuticals Market Outlook, By Prescription Medicines (2023-2034) ($MN)
  • Table 93 Global Veterinary Pharmaceuticals Market Outlook, By Over-the-Counter (OTC) Medicines (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.